Source / episode info
- **Episode:**353
- **Title:**Divine Intervention Episode 353 – The Clutch Pulmonary HTN Podcast (for Step 1-3)
- **Published:**2021-11-24
- Source:Episode page
One-liner
This episode provides a comprehensive review of pulmonary hypertension, covering its diverse etiologies (PAH, COPD, Scleroderma, LHF), the critical hemodynamic differentiation between proximal and distal causes, diagnostic gold standards, and the underlying molecular mechanisms of vasodilation.
High-yield summary
- Definition: Pulmonary Hypertension (PH) is defined by a mean pulmonary arterial pressure > 25 mmHg. The primary risk is right ventricular failure due to chronic increased afterload.
- Hemodynamic Differentiation: PH from Pulmonary Arterial causes (proximal problem, e.g., PAH) results in high Central Venous Pressure (CVP) but normal or low Pulmonary Capillary Wedge Pressure (PCWP). Conversely, PH from Left Heart Failure/Venous causes (distal problem, e.g., Mitral Stenosis) results in elevated both CVP and PCWP.
- Key Etiologies: Common causes include PAH (e.g., BMPR2 mutation), chronic hypoxia (COPD, IPF, OSA, Cystic Fibrosis), drug use (cocaine, methamphetamines), connective tissue disease (Scleroderma/CREST).
- Pathophysiology of Vasodilation: PH involves decreased vasodilators like Nitric Oxide (NO) and Prostaglandins. Treatment targets include PDE5 inhibitors (e.g., Sildenafil), Endothelin Receptor Antagonists (ERA, e.g., Ambrisentan), and Prostacyclin analogs (PGI2 analogs, e.g., Iloprost).
- Diagnosis: The screening test is an echocardiogram; the definitive diagnostic test is Right Heart Catheterization using a Swan-Ganz catheter to measure pulmonary pressures and PCWP.
Learning objectives
- Differentiate the hemodynamic profiles (CVP vs PCWP) of pulmonary arterial hypertension versus pulmonary venous hypertension.
- Identify common etiologies of PH based on clinical presentation (e.g., COPD for hypoxia; MS for LHF).
- Understand the molecular targets and mechanisms of key anti-PH medications (PDE5 inhibitors, ERAs, Prostaglandin analogs).
- Interpret basic cardiac catheterization findings to distinguish between right heart failure due to PAH versus left heart failure.
- Recognize the clinical signs and diagnostic approach for Persistent Pulmonary Hypertension of the Newborn (PPHN).
Board exam buzzwords